NHS patients will be the first in Europe to benefit from a non-invasive liver cancer treatment, as the Government slashes red tape and drives innovation.
In the first of a regular feature from each region of the Health Innovation Network, Richard Stubbs, chief executive of Health Innovation Yorkshire and Humber, shares how AI is improving cancer dia...
NICE is recommending capivasertib with fulvestrant to treat women with advanced breast cancer, which means the drug will be funded immediately through the Cancer Drugs Fund.
Increasing workforce supply and disease awareness and prevention - at pace
The National Pathology Imaging Co-operative (NPIC) at Leeds Teaching Hospitals NHS Trust will receive £5.1m from the government to improve data infrastructure that will aid cancer and disease resea...
Oldham, Greater Manchester£104,337 – £115,105
Bradford, West Yorkshire£96,350 – £108,925
Oldham, Greater Manchester£104,337 – £115,105
Bradford, West Yorkshire£96,350 – £108,925